18F-FCOB04

N/A

Report date: 2026/03/16 20:01:47

NME

Base Information

Drug Name18F-FCOB04

Drug Alias Name18F-FCOB0418F-FCOB-04

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs

Mechanisms of ActionMonoamine oxidase B modulatorsPositron-emission tomography enhancers

TargetsMonoamine oxidase B

Therapy Area/IndicationsNeurodegenerative Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPeking Union Medical College Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital

Inactive CompaniesN/A

Active IndicationsNeurodegenerative Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A